RxSight, Inc. (RXST)
5.81
-0.97
(-14.31%)
USD |
NASDAQ |
May 07, 13:19
RxSight EPS Diluted (Quarterly) : -0.2223 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alphatec Holdings, Inc. | -0.2201 |
| Abbott Laboratories | 0.6165 |
| Accuray, Inc. | -0.1138 |
| Boston Scientific Corp. | 0.897 |
| Plus Therapeutics, Inc. | -1.03 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.152M |
| Revenue (Quarterly) | 32.61M |
| Total Expenses (Quarterly) | 41.76M |
| Enterprise Value | 62.70M |
| Gross Profit Margin (Quarterly) | 77.47% |
| Profit Margin (Quarterly) | -28.07% |
| Earnings Yield | -16.41% |
| Normalized Earnings Yield | -16.41 |